<DOC>
	<DOCNO>NCT00600990</DOCNO>
	<brief_summary>The purpose study determine effectiveness medication prevent nausea vomit female patient risk post-operative nausea vomiting ( PONV ) .</brief_summary>
	<brief_title>Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients</brief_title>
	<detailed_description>A Multicenter , Randomized , Double-blind , Double-dummy , Placebo-controlled , Parallel Group , Phase II Study Evaluate Safety , Efficacy , Pharmacokinetics Oral ( 25 mg ) Intravenous ( 3 mg 18 mg ) Formulations Neurokinin-1 Receptor Antagonist , GW597599 , When Administered Intravenous Ondansetron Hydrochloride Prevention Post-operative Nausea Vomiting Post-discharge Nausea Vomiting Female Subjects Known Risk Factors PONV Who Undergoing Surgical Procedures Associated Increased Emetogenic Risk</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Postoperative Nausea Vomiting</mesh_term>
	<mesh_term>Vestipitant</mesh_term>
	<criteria>know risk factor PONV . Undergoing gynecological gallbladder surgery .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>post-operative nausea vomit</keyword>
	<keyword>PONV</keyword>
</DOC>